| Trial ID: | L0040 |
| Source ID: | NCT03281083
|
| Associated Drug: |
Levothyroxine
|
| Title: |
Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease|Diabetes Mellitus, Type 2
|
| Interventions: |
Drug: Levothyroxine Sodium
|
| Outcome Measures: |
Liver fat content|HbA1c|Lipid profile|Abdominal fat
|
| Sponsor/Collaborators: |
Duke-NUS Graduate Medical School|Singapore Clinical Research Institute|Singapore Institute for Clinical Sciences|Institute of Bioengineering and Bioimaging (IBB)|Tan Tock Seng Hospital|Singapore General Hospital|Ng Teng Fong General Hospital|Changi Genera
|
| Gender: |
Male
|
| Age: |
21 Years to 60 Years ?? (Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
29
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
March 28, 2014
|
| Completion Date: |
July 28, 2016
|
| Results First Posted: |
--
|
| Last Update Posted: |
September 14, 2017
|
| Locations: |
--
|
| URL: |
https://ClinicalTrials.gov/show/NCT03281083
|
